# Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)

> **NCT01733459** · PHASE3 · COMPLETED · sponsor: **Dexa Medica Group** · enrollment: 124 (actual)

## Conditions studied

- Polycystic Ovary Syndrome (PCOS)

## Interventions

- **DRUG:** DLBS3233
- **DRUG:** Metformin XR
- **DRUG:** Placebo caplet of Metformin XR
- **DRUG:** Placebo capsule of DLBS3233

## Key facts

- **NCT ID:** NCT01733459
- **Lead sponsor:** Dexa Medica Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2018-04
- **Final completion:** 2018-06
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2018-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01733459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01733459, "Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01733459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*